Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

2.3K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.3K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

313
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
313
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

443
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
443
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

436
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
436
  1. Home
  3. Multidisciplinary Management Of Duchenne Muscular Dystrophy From Childhood To Adulthood.
  1. Home
  3. Multidisciplinary Management Of Duchenne Muscular Dystrophy From Childhood To Adulthood.

Related Experiment Video

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.8K

Multidisciplinary management of Duchenne muscular dystrophy from childhood to adulthood.

Juliette Ropars1, Emmanuelle Salort-Campana2

  • 1Department of Pediatrics, CHU Brest, 29200 Brest, France; Neuromuscular center, 29200 Brest, France; Laboratoire du Traitement de l'Information Médicale, LaTIM INSERM UMR1101, 29200 Brest, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|December 14, 2025

View abstract on PubMed

Summary
This summary is machine-generated.

Managing Duchenne muscular dystrophy (DMD) requires a lifelong, multidisciplinary approach. Tailored care across childhood, transition, and adulthood optimizes quality of life and outcomes for individuals with this progressive neuromuscular disorder.

Keywords:
Duchenne muscular dystrophyMultidisciplinary managementTransition

More Related Videos

Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

33.6K
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.4K

Related Experiment Videos

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.8K
Assessing Functional Performance in the Mdx Mouse Model
10:32

Assessing Functional Performance in the Mdx Mouse Model

Published on: March 27, 2014

33.6K
Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
08:13

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

6.4K

Area of Science:

  • Neurology
  • Genetics
  • Rehabilitation Medicine

Background:

  • Duchenne muscular dystrophy (DMD) is a severe, progressive neuromuscular disorder causing muscle degeneration and multisystem complications.
  • Effective management necessitates a coordinated, multidisciplinary strategy focused on patient quality of life throughout their lifespan.
  • Early diagnosis and proactive interventions are crucial for optimizing outcomes in DMD patients.

Purpose of the Study:

  • To outline the principles of multidisciplinary care for Duchenne muscular dystrophy (DMD).
  • To emphasize tailored interventions across different life stages for DMD patients.
  • To address the challenges of care transition and ethical considerations in advanced DMD management.

Main Methods:

  • Review of current principles in multidisciplinary care for Duchenne muscular dystrophy.
  • Analysis of evolving patient needs from childhood through adulthood.
  • Examination of transition programs bridging pediatric and adult care systems.
  • Consideration of ethical aspects, including anticipatory directives.

    • Main Results:

    • DMD management requires distinct, coordinated approaches for pediatric, transitional, and adult phases.
    • Key interventions include physical therapy, respiratory and cardiac support, orthopedic care, and psychosocial support.
    • Effective transition programs are vital for continuity of care and integration into adult life.
    • Anticipatory planning and directives are essential for aligning care with patient preferences.

    Conclusions:

    • A lifelong, multidisciplinary approach is fundamental for improving quality of life and longevity in DMD.
    • Tailored medical, psychosocial, and rehabilitative strategies are critical at each life stage.
    • Addressing the complexities of care transition and ethical planning enhances patient outcomes and well-being.